RehabilitationRehablinesNCT06750601
Rehablines: a Further Use Databank to (re)Use Routine Clinical Data for Scientific Research in Rehabilitation of People With Physical Disabilities and/or Chronic Diseases
An observational study of Rehabilitation, run by University Medical Center Groningen at 1 site in Netherlands.
Trial summary
Within the Center of Rehabilitation multidisciplinary treatment is provided to people with various physical disabilities and/or chronic diseases. During and in the context of this treatment, a lot of data is routinely collected. Read more about this study
- Who is it for?
- Any age
- Conditions the study is for
- Rehabilitation
- How many people
- 20,000 participants
- Where
- 1 siteNetherlands
- Study dates
- 1 Aug 2023to Jan 2044
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Study population: In the UMCG-CvR rehabilitation care is provided to patients with a variety of physical disabilities and/or chronic diseases. Provided types of rehabilitation include for instance neurorehabilitation, orthopedic rehabilitation, oncology rehabilitation, pain rehabilitation, pediatric rehabilitation and rehabilitation in chronic illnesses, e.g. heart, lung, diabetes, thoracic and transplant rehabilitation. All patients who are starting their treatment in our facility are invited to participate in Rehablines.
Who may be able to join
- all participants receiving care at the Center for Rehabilitation of the University Medical Center Groningen
Who cannot join
- n.a.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Netherlands1 site, 1 recruiting
- Recruiting
Center for Rehabilitation of the University Medical Center Groningen
Groningen, 9700 RB
K van Kammen, PhD, +3150 - 361 6160, rehablines@umcg.nl
About this study
Within the Center of Rehabilitation multidisciplinary treatment is provided to people with various physical disabilities and/or chronic diseases. During and in the context of this treatment, a lot of data is routinely collected. Rehablines is initiated to re-use this routine clinical data in a database for future scientific research. Rehablines aims to: - Efficiently conduct high quality scientific research aimed at patient characteristics, underlying disease processes, and treatment effects; - Provide insight into (short and long-term) treatment effects and efficiency of these rehabilitation treatments; - Personalize treatment by comparing data from the individual patient with data from a large number of patients with similar characteristics from Rehablines.
- Conditions
- Rehabilitation
What is being measured
The primary outcome is the main question the study is designed to answer.
Clinical data
Rehablines is a unique databank that purely re-uses clinical data for research. All data that is collected during the treatment of our patients can be re-used with patient consent.
Measured: Timepoint 1: pre-treatment. Timepoint 2: throughout study completion (on average 12 weeks). Timepoint 3: up to 1 year follow up
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted27 Dec 2024
- Study start1 Aug 2023
- Primary completionJan 2044 (estimated)
- Study completionJan 2044 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for RehabilitationStudies of the same condition, open and under way.
- More trials run by University Medical Center GroningenThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Retrospective
- Enrolment
- 20,000 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University Medical Center Groningen
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06750601
- Sponsor's protocol ID
- UMCG RR number: 16881
- Acronym
- Rehablines
- Status last verified
- Dec 2024
- First submitted
- 9 Dec 2024
- Last updated
- 27 Dec 2024
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Publications
van Kammen K, Krops LA, Geertzen JHB, Dekker R. Rehablines: a Dutch further use databank to (re)use routine real world clinical data for scientific research in rehabilitation of people with physical disabilities and/or chronic diseases - a cohort profile. BMJ Open. 2025 Aug 8;15(8):e099089. doi: 10.1136/bmjopen-2025-099089.
PubMed 40780713
Study at a glance
From the registry record, last updated by the sponsor on 27 Dec 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Rehablines: a Further Use Databank to (re)Use Routine Clinical Data for Scientific Research in Rehabilitation of People With Physical Disabilities and/or Chronic Diseases
- ClinicalTrials.gov ID
- NCT06750601
- Acronym / sponsor ID
- Rehablines / UMCG RR number: 16881
- Conditions
- Rehabilitation
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 20,000 participants (estimated)
- Lead sponsor
- University Medical Center GroningenUniversity, hospital or other
- Study start
- 1 Aug 2023 (actual)
- Primary completion
- Jan 2044 (estimated)
- Study completion
- Jan 2044 (estimated)
- First posted
- 27 Dec 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Within the Center of Rehabilitation multidisciplinary treatment is provided to people with various physical disabilities and/or chronic diseases. During and in the context of this treatment, a lot of data is routinely collected. Rehablines is initiated to re-use this routine clinical data in a database for future scientific research. Rehablines aims to: - Efficiently conduct high quality scientific research aimed at patient characteristics, underlying disease processes, and treatment effects; - Provide insight into (short and long-term) treatment effects and efficiency of these rehabilitation treatments; - Personalize treatment by comparing data from the individual patient with data from a large number of patients with similar characteristics from Rehablines.
Study design
- Observational model
- Cohort
- Time perspective
- Retrospective
Who may qualify
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
- Study population
- In the UMCG-CvR rehabilitation care is provided to patients with a variety of physical disabilities and/or chronic diseases. Provided types of rehabilitation include for instance neurorehabilitation, orthopedic rehabilitation, oncology rehabilitation, pain rehabilitation, pediatric rehabilitation and rehabilitation in chronic illnesses, e.g. heart, lung, diabetes, thoracic and transplant rehabilitation. All patients who are starting their treatment in our facility are invited to participate in Rehablines.
Key inclusion criteria (1 listed)
- all participants receiving care at the Center for Rehabilitation of the University Medical Center Groningen
Key exclusion criteria (1 listed)
- n.a.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Clinical data
Time frame: Timepoint 1: pre-treatment. Timepoint 2: throughout study completion (on average 12 weeks). Timepoint 3: up to 1 year follow up
Rehablines is a unique databank that purely re-uses clinical data for research. All data that is collected during the treatment of our patients can be re-used with patient consent.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 27 Dec 2024.
- Derived from this study: PubMed 40780713van Kammen K, Krops LA, Geertzen JHB, Dekker R. Rehablines: a Dutch further use databank to (re)use routine real world clinical data for scientific research in rehabilitation of people with physical disabilities and/or chronic diseases - a cohort profile. BMJ Open. 2025 Aug 8;15(8):e099089. doi: 10.1136/bmjopen-2025-099089.
- Individual participant dataSharing planned: Undecided
Related trials for Rehabilitation
Recruiting
Cervical tsDCS on Stroke Patients
Functional Recovery, Motor Rehabilitation
Not yet recruiting
Accessible Remote Rehabilitation System for Real-Time Biomechanical Monitoring
Hand Injury Rehabilitation, Postoperative Rehabilitation
Recruiting
Transcranial Alternating Current Stimulation (tACS) Combined With Cognitive Training in Alzheimer's Disease
Transcranial Alternating Current Stimulation, Alzheimer Disease (AD)
Not yet recruitingEarly Phase 1
Early Botulinum Toxin for Muscle Stiffness Reduction in First-Time Stroke Patients: Improving Recovery and Independence
Spasticity, Stroke
RecruitingObservational study
Early Postoperative Pain Following a Limb Amputation
Amputation, Surgical, Pain Management
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Rehabilitation, run by University Medical Center Groningen at 1 site in Netherlands.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 27 Dec 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Netherlands. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact K van Kammen, PhD, PhD (+3150 - 361 6160, rehablines@umcg.nl), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Clinical data (time frame: Timepoint 1: pre-treatment. Timepoint 2: throughout study completion (on average 12 weeks). Timepoint 3: up to 1 year follow up). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT06750601, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Dec 2024; AzTrials last refreshed its copy on 7 Nov 2026.